|Reviewer||Representation||Employment||Consultant||Speakers Bureau||Ownership/Partnership/Principal||Personal Research||Institutional, Organizational, or Other Financial Benefit||Expert Witness|
|Luis C. Afonso||ACC||Wayne State University Division of Cardiology||None||None||None||None||None||None|
|Zahid Amin||SCAI||Georgia Regents University||None||None||None||None||None||None|
|Carol Chen-Scarbelli||HRS||VA Ann Arbor Healthcare System||None||None||None||None||None||None|
|Mina K. Chung||HRS||Cleveland Clinic Lerner College of Medicine of Case Western Reserve University||None||None||None||None|
|Joaquin E. Cigarroa||ACC||Oregon Health and Science University||None||None||None||None||None||None|
|Amrit Guptan||HRS||Heart Rhythm Specialists||None||None||None||None||None||None|
|Jonathan L. Halperin||ACC||Mt. Sinai Medical Center||None||None||None||None||None|
|Zihad M. Hijazi||SCAI||Sidra Medical and Research Center||None||None||None||None||None|
|Julia H. Indik||HRS||University of Arizona Medical Center||None||None||None||None||None|
|Craig T. January||ACC||University of Wisconsin Hospital Clinical Cardiology Section||None||None||None||None||None||None|
|James J. Januzzi||ACC||Massachusetts General Hospital||None||None||None||None||None||None|
|Dharam J. Kumbhani||ACC||University of Texas Southwestern Medical Center||None||None||None||None||None||None|
|Rick A. Nishimura||ACC||Mayo Clinic, Division of Cardiovascular Diseases||None||None||None||None||None||None|
|Marwan M. Refaat||ACC||American University of Beirut||None||None||None||None||None||None|
|David J. Slotwiner||HRS||Long Island Jewish Medical Center||None||None||None||None||None||None|
|Zoltan G. Turi||SCAI||Robert Wood Johnson University Hospital||None||None||None||None||None||None|
|E. Murat Tuzcu||ACC||Cleveland Clinic||None||None||None||None||None|
|L. Samuel Wann||ACC||Columbia St. Mary's Healthcare||None||None||None||None||None||None|
|Eric S. Williams||ACC||Indiana University School of Medicine, Krannert Institute of Cardiology||None||None||None||None||None||None|
This table represents the relationships of reviewers with industry and other entities that were disclosed at the time of peer review and determined to be relevant to this document. It does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of >5% of the voting stock or share of the business entity, or ownership of >$5,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person's gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted. A person has a relevant relationship IF: a) the relationship or interest relates to the same or similar subject matter, intellectual property or asset, topic, or issue addressed in the document; or b) the company/entity (with whom the relationship exists) makes a drug, drug class, or device addressed in the document, or makes a competing drug or device addressed in the document; or c) the person or a member of the person's household, has a reasonable potential for financial, professional or other personal gain or loss as a result of the issues/content addressed in the document.
ACC, American College of Cardiology; HRS, the Heart Rhythm Society; SCAI, the Society for Cardiovascular Angiography and Interventions; and VA, Veterans Affairs.
↵a No financial benefit.